PropertyValue
?:abstract
  • Increased morbidity and mortality from SARS-CoV-2 coronavirus disease (COVID-19) in people with obesity has illuminated the intersection of obesity with impaired responses to infections. While data is being rapidly generated on mechanisms by which COVID-19 impacts health, there is a critical need to better understand the pulmonary, vascular, metabolic, and immunologic aspects that drive the increased risk for complications from COVID-19 in people with obesity. In this review, we provide a broad overview of the intersection between COVID-19 and physiology of obesity to highlight potential mechanisms by which COVID-19 disease severity is increased by obesity, and to identify areas for future investigation towards developing tailored therapy for people with obesity who develop COVID-19.
is ?:annotates of
?:creator
?:journal
  • Obesity_(Silver_Spring)
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Pathways to Severe COVID-19 for People with Obesity
?:type
?:who_covidence_id
  • #956181
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/odym0ovu>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/odym0ovu>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all